Robert H. Purcell
78Patents
11h-index
54Co-inventors
81Inventor score
Filing activity: Apr 11, 1977 → Apr 28, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5514539A | Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines | Emerging Cross-Sectional Technologies | 62 | Expired |
| US6153421A | Cloned genomes of infectious hepatitis C viruses and uses thereof | Chemistry; Metallurgy | 33 | Expired |
| US4615886A | Utilizing a halohydrocarbon containing dissolved water to inactivate a lipid virus | Human Necessities | 27 | Expired |
| US4894228A | Vaccine against hepatitis A virus | Emerging Cross-Sectional Technologies | 23 | Expired |
| US4581231A | Inactivation of viruses containing essential lipids | Chemistry; Metallurgy | 22 | Expired |
| US5882852A | Hepatitic C virus (HCV) core gene nucleotide sequences and related methods of detecting major and minor genotypes of HCV isolates | Emerging Cross-Sectional Technologies | 16 | Expired |
| US4140761A | Modification of hepatitis B virus infection in chronic carriers of hepatitis B surface antigen | Human Necessities | 15 | Expired |
| US6180110A | Attenuated hepatitis a virus vaccine which grows in MRC-5 cells | Emerging Cross-Sectional Technologies | 14 | Expired |
| US7622113B2 | Monoclonal antibodies that bind or neutralize dengue virus | Emerging Cross-Sectional Technologies | 13 | Expired |
| US4620978A | Hepatitis A virus purified and triply cloned | Emerging Cross-Sectional Technologies | 12 | Expired |
| US5516630A | Methods of detecting hepatitis A virus | Emerging Cross-Sectional Technologies | 11 | Expired |
| US4532215A | Isolation of hepatitis A virus strain HM-175 | Emerging Cross-Sectional Technologies | 10 | Expired |
| US4636469A | Isolation of hepatitis A virus strain HM-175 | Emerging Cross-Sectional Technologies | 8 | Expired |
| US4511556A | Inactivation of a lipid virus | Chemistry; Metallurgy | 7 | Expired |
| US6113912A | Hepatitis A virus vaccines | Emerging Cross-Sectional Technologies | 7 | Expired |
| US5871962A | Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6287759A | Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines | Emerging Cross-Sectional Technologies | 7 | Expired |
| US7084266B1 | Cloned genome of infectious hepatitus C virus of genotype 2A and uses thereof | Chemistry; Metallurgy | 7 | Expired |
| US6572864B1 | Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines | Emerging Cross-Sectional Technologies | 6 | Expired |
| US8337854B2 | Monoclonal antibodies against dengue and other viruses with deletion in Fc region | Emerging Cross-Sectional Technologies | 6 | Active |
| US5476658A | Vaccine against hepatitis a comprising simian HAV isolate AGM-27 | Emerging Cross-Sectional Technologies | 6 | Expired |
| US8337853B2 | Monoclonal antibodies that bind or neutralize dengue virus | Emerging Cross-Sectional Technologies | 6 | Active |
| US6054567A | Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines | Physics | 6 | Expired |
| US6423318B1 | Hepatitis A virus vaccines | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5849562A | Production of complementary DNA representing hepatitis A viral sequences by recombinant DNA methods and uses therefor | Emerging Cross-Sectional Technologies | 6 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.